 |
 |
DRUG DELIVERY RESEARCH |
| |
| Capabilities |
|
- Development of a wide range of dosage forms including
tablets, capsules, injectibles, liquid orals and ointments, creams and gels
- Core competency
- Development of novel modified release solid oral dosage
forms
- Development of poorly soluble drugs to enhance solubility
and bioavailability
- Parenteral delivery of proteins and peptides
- Development of Niosomal/Liposomal products with improved
absorption and efficacy
|
|
| Achievements |
|
- Development of generics products for regulated markets:
- Metformin IR tablets
- Glimepiride tablets
- Technology transfer to Green Cross of Korea for Metformin
SR tablets
- Trimetazidine tablets 60mg once daily for the Indian market
- Irritation and stain free Dithranol micro-emulsion cream
for psoriasis with improved efficacy
- Supra bioavailable formulation of Fenofibrate tablets
- 7 ANDAs filed with US-FDA
- 2 ANDAs approved and commercial supplies commenced
|
|
| Infrastructure |
|
- Rapid mixer granulators
- Fluid bed processors
- Rotary tablet presses for multilayered tablets
- Autocoater for film coating of pellets and tablets
- Blister packing machines (cold form and Alu poly)
- High speed homogenizers
- Extruder and spheronizer
- Walk-in stability chambers compliant to ICH requirements
- Microscope with polarizing light
- Lyophilizer
- Fluid bed processor with top spray & Wurster facility
- Automatic high speed encapsulator with devices to fill tablets and pellets in the capsule
|
|
|
|
|
|
|
